Education
About Us
Working with TipRanks
Follow Us
Icon plc (ICLR)
NASDAQ:ICLR
ICLR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$179.50 - $347.72
Previous CloseN/A
Volume330.38K
Average Volume (3M)961.95K
Market Cap
$14.76B
Enterprise Value$26.86B
Total Cash (Recent Filing)$538.78M
Total Debt (Recent Filing)$3.57B
Price to Earnings (P/E)19.2
Beta1.19
Next Earnings
Apr 23, 2025EPS Estimate
3.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.54
Shares Outstanding80,756,860
10 Day Avg. Volume945,705
30 Day Avg. Volume961,954
Financial Highlights & Ratios
PEG Ratio0.66
Price to Book (P/B)N/A
Price to Sales (P/S)1.82
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.82
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit11.02
Enterprise Value/Ebitda16.38
Forecast
1Y Price Target
$252.14Price Target Upside43.44% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
---
Icon News
PremiumCompany Announcements
ICON plc Reports Strong Interim Financial Results for 2024-2025
PremiumCompany Announcements
ICON plc to Present at Major Healthcare Conferences---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceICLR reported a quarter that showed signs of stabilization to modest improvement.
Share RepurchaseICLR's recently-increased share repurchase authorization may allow the company to take advantage of the depressed stock valuation.
Bears Say
Revenue ImpactThe lost revenue from the trial delay will be felt, with potential decremental margin risk due to idle resource allocation.
Trial DelaysThe delay of a Covid vaccine trial is another market-driven challenge piling on recent pressures for ICLR and the broader CRO landscape.
---
Ownership Overview
1.96% Insiders
27.32% Mutual Funds
43.37% Other Institutional Investors
26.17% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ICLR FAQ
What was Icon plc’s price range in the past 12 months?
Icon plc lowest stock price was $179.50 and its highest was $347.72 in the past 12 months.
What is Icon plc’s market cap?
Icon plc’s market cap is $14.76B.
When is Icon plc’s upcoming earnings report date?
Icon plc’s upcoming earnings report date is Apr 23, 2025 which is in 42 days.
How were Icon plc’s earnings last quarter?
Icon plc released its earnings results on Feb 19, 2025. The company reported $3.43 earnings per share for the quarter, beating the consensus estimate of $3.428 by $0.002.
Is Icon plc overvalued?
According to Wall Street analysts Icon plc’s price is currently Undervalued.
Does Icon plc pay dividends?
Icon plc does not currently pay dividends.
What is Icon plc’s EPS estimate?
Icon plc’s EPS estimate is 3.17.
How many shares outstanding does Icon plc have?
Icon plc has 80,756,860 shares outstanding.
What happened to Icon plc’s price movement after its last earnings report?
Icon plc reported an EPS of $3.43 in its last earnings report, beating expectations of $3.428. Following the earnings report the stock price went up 5.499%.
Which hedge fund is a major shareholder of Icon plc?
Currently, no hedge funds are holding shares in ICLR
---
Icon Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$252.14 (43.44% Upside)
$252.14 (43.44% Upside)
Blogger Sentiment
Bullish
ICLR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 232.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $367.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days <0.1%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.39%
12-Months-Change
Fundamentals
Return on Equity
8.44%
Trailing 12-Months
Asset Growth
-0.66%
Trailing 12-Months
Company Description
Icon plc
ICON plc (ICLR) is a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government organizations. The company operates within the life sciences sector, offering a comprehensive range of services that cover all stages of the clinical development process, from Phase I to Phase IV clinical trials. ICON's core services include clinical trial management, data analytics, regulatory consulting, and laboratory services, all designed to accelerate the development of new medical treatments and ensure regulatory compliance.
---
ICLR Company Deck
---
ICLR Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with significant progress in business development and cost management, yet faced challenges with revenue decline and elevated cancellations. The demand environment remains volatile, especially in the biotech sector, impacting overall growth expectations.Read More>---
ICLR Stock 12 Month Forecast
Average Price Target
$252.14
▲(43.44% Upside)
Technical Analysis
Best Analysts Covering ICLR
1 Year
1 Year Success Rate
20/32 ratings generated profit
1 Year Average Return
+3.82%
reiterated a buy rating 23 days ago
Copying Ann Hynes's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +3.82% per trade.
---